$LGND Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 7 ... 15 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	56.26	7,077	398,152	41,294	34.2 K to 41.3 K (+20.68 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	74.42	5,985	445,404	34,217	28.2 K to 34.2 K (+21.20 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	M	21.92	469	10,280	28,232	27.8 K to 28.2 K (+1.69 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	12.53	3,335	41,788	0
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Sell	S	254.96	3,335	850,292	21,449	24.8 K to 21.4 K (-13.46 %)
Sep 05 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	12.53	3,335	41,788	24,784	21.4 K to 24.8 K (+15.55 %)
Aug 31 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	258.25	3,500	903,875	85,419	88.9 K to 85.4 K (-3.94 %)
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Option Exercise	M	85.79	11,540	990,017	6,924
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Sell	S	256.69	18,357	4,712,060	6,742	25.1 K to 6.7 K (-73.14 %)
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Buy	M	85.79	11,540	990,017	25,099	13.6 K to 25.1 K (+85.11 %)
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Option Exercise	M	85.79	11,540	990,017	6,924
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Sell	S	256.69	18,357	4,712,060	6,742	25.1 K to 6.7 K (-73.14 %)
Aug 29 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Buy	M	85.79	11,540	990,017	25,099	13.6 K to 25.1 K (+85.11 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	241.81	26,862	6,495,559	51,392	78.3 K to 51.4 K (-34.33 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	245.00	1,080	264,600	78,254	79.3 K to 78.3 K (-1.36 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	239.50	3,167	758,497	45,056	48.2 K to 45.1 K (-6.57 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	239.93	5,833	1,399,505	48,223	54.1 K to 48.2 K (-10.79 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	14.47	12,993	188,009	159,000
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	14.47	3,007	43,511	171,993
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	243.00	12,993	3,157,299	88,919	101.9 K to 88.9 K (-12.75 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	14.47	12,993	188,009	101,912	88.9 K to 101.9 K (+14.61 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	241.33	21,507	5,190,261	88,919	110.4 K to 88.9 K (-19.48 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	14.47	3,007	43,511	110,426	107.4 K to 110.4 K (+2.80 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	M	32.30	7,335	236,921	0
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	M	12.53	7,335	91,908	0
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	M	10.12	7,335	74,230	0
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	M	9.60	5,000	48,000	0
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Sell	S	240.05	42,287	10,150,808	24,524	66.8 K to 24.5 K (-63.29 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Buy	M	32.30	7,335	236,921	66,811	59.5 K to 66.8 K (+12.33 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Buy	M	12.53	7,335	91,908	59,476	52.1 K to 59.5 K (+14.07 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Buy	M	10.12	7,335	74,230	52,141	44.8 K to 52.1 K (+16.37 %)
Aug 17 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Buy	M	9.60	5,000	48,000	44,806	39.8 K to 44.8 K (+12.56 %)
Aug 07 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	226.74	836	189,555	13,559	14.4 K to 13.6 K (-5.81 %)
Jul 03 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	207.48	2,500	518,699	28,642	31.1 K to 28.6 K (-8.03 %)
Jul 03 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Buy	J	117.84	180	21,210	14,395	14.2 K to 14.4 K (+1.27 %)
Jul 03 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Buy	J	117.84	180	21,210	27,763	27.6 K to 27.8 K (+0.65 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	493	0	39,806	39.3 K to 39.8 K (+1.25 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	493	0	39,806	39.3 K to 39.8 K (+1.25 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	493	0	54,056	53.6 K to 54.1 K (+0.92 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	493	0	54,056	53.6 K to 54.1 K (+0.92 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Grant	A	0.00	493	0	1,406	913 to 1.4 K (+54.00 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Grant	A	0.00	493	0	1,406	913 to 1.4 K (+54.00 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	493	0	59,118	58.6 K to 59.1 K (+0.84 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	493	0	59,118	58.6 K to 59.1 K (+0.84 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	493	0	21,449	21 K to 21.4 K (+2.35 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	493	0	21,449	21 K to 21.4 K (+2.35 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	493	0	31,142	30.6 K to 31.1 K (+1.61 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	493	0	31,142	30.6 K to 31.1 K (+1.61 %)
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	A	76.77	2,474	189,929	2,474
Jun 21 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	0.00	493	0	26,856	26.4 K to 26.9 K (+1.87 %)
Jun 04 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	12.53	4,000	50,120	3,335
Jun 04 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Sell	S	194.51	4,000	778,039	20,956	25 K to 21 K (-16.03 %)
Jun 04 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	12.53	4,000	50,120	24,956	21 K to 25 K (+19.09 %)
May 15 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	16.14	12,405	200,217	29,790
May 15 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	179.97	12,405	2,232,491	107,419	119.8 K to 107.4 K (-10.35 %)
May 15 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	16.14	12,405	200,217	119,824	107.4 K to 119.8 K (+11.55 %)
May 11 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	14.47	8,881	128,508	45,675
May 11 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	1,055	10,518	41,026
May 11 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	1,055	10,518	102,256	101.2 K to 102.3 K (+1.04 %)
May 11 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	167.63	8,881	1,488,687	101,201	110.1 K to 101.2 K (-8.07 %)
May 11 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	14.47	8,881	128,508	110,082	101.2 K to 110.1 K (+8.78 %)
Apr 03 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	160.43	2,500	401,063	30,649	33.1 K to 30.6 K (-7.54 %)
Mar 13 2018	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Sell	S	180.73	622	112,414	26,363	27 K to 26.4 K (-2.30 %)
Mar 09 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	176.48	4,000	705,899	79,334	83.3 K to 79.3 K (-4.80 %)
Mar 09 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	174.88	3,500	612,095	83,334	86.8 K to 83.3 K (-4.03 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	10.12	3,335	33,750	0
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Sell	S	160.90	3,335	536,604	20,956	24.3 K to 21 K (-13.73 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	10.12	3,335	33,750	24,291	21 K to 24.3 K (+15.91 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Option Exercise	A	159.01	16,050	2,552,111	16,050
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	165.87	550	91,229	14,215	14.8 K to 14.2 K (-3.73 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	2,004	0	14,765	12.8 K to 14.8 K (+15.70 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Grant	A	0.00	3,074	0	12,761	9.7 K to 12.8 K (+31.73 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Option Exercise	A	159.01	9,292	1,477,521	9,292
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	165.87	392	65,021	27,583	28 K to 27.6 K (-1.40 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,136	0	27,975	26.8 K to 28 K (+4.23 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Grant	A	0.00	1,780	0	26,839	25.1 K to 26.8 K (+7.10 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	A	159.01	41,392	6,581,742	41,392
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	165.87	2,982	494,624	107,419	110.4 K to 107.4 K (-2.70 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	6,015	0	110,401	104.4 K to 110.4 K (+5.76 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	7,928	0	104,386	96.5 K to 104.4 K (+8.22 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	A	159.01	20,274	3,223,769	20,274
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	165.87	1,457	241,673	101,201	102.7 K to 101.2 K (-1.42 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	2,940	0	102,658	99.7 K to 102.7 K (+2.95 %)
Mar 06 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	3,883	0	99,718	95.8 K to 99.7 K (+4.05 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	155.00	3,417	529,635	86,834	90.3 K to 86.8 K (-3.79 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Gift	G	0.00	1,000	0	58,625	59.6 K to 58.6 K (-1.68 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	151.90	12,335	1,873,709	53,563	65.9 K to 53.6 K (-18.72 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	153.58	4,835	742,536	65,898	70.7 K to 65.9 K (-6.84 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	14.47	5,444	78,775	54,556
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	1,004	10,010	42,081
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	152.98	5,444	832,824	95,835	101.3 K to 95.8 K (-5.38 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	14.47	5,444	78,775	101,279	95.8 K to 101.3 K (+5.68 %)
Feb 27 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	1,004	10,010	95,835	94.8 K to 95.8 K (+1.06 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	157.18	260	40,867	25,059	25.3 K to 25.1 K (-1.03 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	157.18	252	39,609	25,319	25.6 K to 25.3 K (-0.99 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	SVP, Gen. Counsel & ...	Payment of Exercise	F	157.18	524	82,362	25,571	26.1 K to 25.6 K (-2.01 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	157.18	1,246	195,846	94,831	96.1 K to 94.8 K (-1.30 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	157.18	906	142,405	96,077	97 K to 96.1 K (-0.93 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	157.18	1,511	237,499	96,983	98.5 K to 97 K (-1.53 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	157.18	1,689	265,477	96,458	98.1 K to 96.5 K (-1.72 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	157.18	1,918	301,471	98,147	100.1 K to 98.1 K (-1.92 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	157.18	2,635	414,169	100,065	102.7 K to 100.1 K (-2.57 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	157.03	9,000	1,413,279	102,700	111.7 K to 102.7 K (-8.06 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	157.18	326	51,241	9,687	10 K to 9.7 K (-3.26 %)
Feb 16 2018	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	EVP,Finance & Strat ...	Payment of Exercise	F	157.18	354	55,642	10,013	10.4 K to 10 K (-3.41 %)
Jan 26 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	165.00	22,500	3,712,500	111,700	134.2 K to 111.7 K (-16.77 %)
Jan 22 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	16.14	16,249	262,259	42,195
Jan 22 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	151.93	11,850	1,800,307	134,200	146.1 K to 134.2 K (-8.11 %)
Jan 22 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	155.00	16,249	2,518,595	146,050	162.3 K to 146.1 K (-10.01 %)
Jan 22 2018	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	16.14	16,249	262,259	162,299	146.1 K to 162.3 K (+11.13 %)
Jan 11 2018	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	145.00	2,500	362,500	33,149	35.6 K to 33.1 K (-7.01 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Payment of Exercise	F	138.66	1,530	212,150	10,367	11.9 K to 10.4 K (-12.86 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Grant	A	0.00	3,750	0	11,897	8.1 K to 11.9 K (+46.03 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	138.66	2,971	411,959	98,494	101.5 K to 98.5 K (-2.93 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	5,695	0	101,465	95.8 K to 101.5 K (+5.95 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	138.66	5,199	720,893	146,050	151.2 K to 146.1 K (-3.44 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	9,965	0	151,249	141.3 K to 151.2 K (+7.05 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Payment of Exercise	F	138.66	1,175	162,926	26,095	27.3 K to 26.1 K (-4.31 %)
Dec 29 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Grant	A	0.00	2,847	0	27,270	24.4 K to 27.3 K (+11.66 %)
Dec 27 2017	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Gift	G	0.00	74	0	70,733	70.8 K to 70.7 K (-0.10 %)
Dec 21 2017	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Sell	S	137.25	925	126,956	26,985	27.9 K to 27 K (-3.31 %)
Nov 20 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	140.22	24,400	3,421,368	90,251	114.7 K to 90.3 K (-21.28 %)
Nov 20 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	140.34	2,258	316,888	141,284	143.5 K to 141.3 K (-1.57 %)
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	10.12	4,000	40,480	3,335
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Sell	S	139.79	4,000	559,160	20,956	25 K to 21 K (-16.03 %)
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	10.12	4,000	40,480	24,956	21 K to 25 K (+19.09 %)
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	141.71	5,000	708,550	35,649	40.6 K to 35.6 K (-12.30 %)
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Sell	S	142.63	6,559	935,510	8,147	14.7 K to 8.1 K (-44.60 %)
Nov 17 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	142.53	5,269	750,991	143,542	148.8 K to 143.5 K (-3.54 %)
Oct 17 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.92	11,384	249,537	0
Oct 17 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	143.04	1,744	249,462	148,811	150.6 K to 148.8 K (-1.16 %)
Oct 17 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.92	11,384	249,537	150,555	139.2 K to 150.6 K (+8.18 %)
Sep 06 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.00	5,000	105,000	0
Sep 06 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	130.00	5,000	650,000	139,171	144.2 K to 139.2 K (-3.47 %)
Sep 06 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.00	5,000	105,000	144,171	139.2 K to 144.2 K (+3.59 %)
Aug 25 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	127.99	2,000	255,980	114,651	116.7 K to 114.7 K (-1.71 %)
Aug 22 2017	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Option Exercise	A	126.26	3,452	435,850	3,452
Aug 22 2017	LGND	LIGAND PHARMACEUTI ...	Gray Nancy Ryan	Director	Grant	A	0.00	913	0	913	0 to 913

Page: < prev 1 2 3 4 5 6 7 ... 15 next >